MCE 的所有产品仅用作科学研究，我们不为任何个人用途提供产品和服务。

1-Naphthohydroxamic acid

CAS No. : 6953-61-3

MCE 站：1-Naphthohydroxamic acid

产品活性：1-Naphthohydroxamic acid (Compound 2) 是一种有效的，选择性的 HDAC8 抑制剂，IC₅₀ 为 14 μM。1-Naphthohydroxamic acid 对 HDAC8 的选择性高于 I 类 HDAC1 和 II 类 HDAC6 (IC₅₀ >100 μM)。1-Naphthohydroxamic acid 不会增加整体组蛋白 H4 的乙酰化，也不会降低总细胞内 HDAC 的活性。1-Naphthohydroxamic acid 可诱导微管蛋白乙酰化。

研究领域：Cell Cycle/DNA Damage  |  Epigenetics

作用靶点：HDAC

In Vitro: 1-Naphthohydroxamic acid (compound 2; 20-40 ?M; 0-144 ?hours; BE(2)-C, SK-N-BE(2) and SH-SY5Y cells) treatment reduces cell numbers in a concentration-dependent manner.
1-Naphthohydroxamic acid (compound 2) at concentrations in the range of its in vitro IC₅₀ against HDAC8 results in reduced cell density and outgrowth of neurite-like structures that stained positive for neurofilament.1-Naphthohydroxamic acid reduces the formation of clones in soft-agar concentration dependently.
When either cell type (HeLa and HEK293 cells) is treated with 1-Naphthohydroxamic acid (compound 2; 0.8 ?M, 4 ?M, 20 ?M or 100 ?M), only tubulin becomes hyperacetylated.

In Vivo: Dose-limiting toxicities (DLTs) of 1-Naphthohydroxamic acid (compound 2; 0-40 mg/kg; intraperitoneal injection; daily; for 10 day; NMRI Foxn1 nude mice) include weight loss and signs of liver toxicity, as evidenced by elevated plasma liver enzymes and detection of necrotic areas on histological liver examination. 1-Naphthohydroxamic acid has the maximum tolerable doses at 50?mg/kg per day. At these concentrations, neither body weight nor blood parameters are critically changed.
Pharmacokinetic studies after intraperitoneal administration of the inhibitors identified the half-life of 1-Naphthohydroxamic acid to be ~15?min, with a plasma peak concentration of ~30?μM.

相关产品：Reprogramming Compound Library  |  Anti-Aging Compound Library  |  Oxygen Sensing Compound Library  |  Anti-Cancer Compound Library  |  Cell Cycle/DNA Damage Compound Library  |  Epigenetics Compound Library  |  Bioactive Compound Library Plus  |  Histone Modification Research Compound Library  |  Trichostatin A  |  Vorinostat  |  Panobinostat  |  Entinostat  |  Valproic acid  |  Romidepsin  |  Sodium Butyrate  |  Sulforaphane  |  Ricolinostat  |  Sodium 4-phenylbutyrate  |  Fimepinostat  |  Belinostat  |  Tucidinostat  |  Mocetinostat  |  RGFP966  |  Tubacin  |  Tubastatin A  |  Quisinostat  |  TMP269  |  Tasquinimod  |  TMP195  |  LMK-235  |  Corin  |  ACY-738  |  Tacedinaline  |  Pracinostat  |  PCI-34051  |  RG2833

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。